Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR1 | Q92633 | 6/20 | 0.55 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | CNR1 | P21554 | 1/20 | 0.53 |
| ▸ | CNR2 | P34972 | 1/20 | 0.53 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4196801 | 0.92 | ALDH1A1 (0.60) | LPAR1LPAR3ALDH1A1CNR1CNR2 | |
| SCHEMBL4094354 | 0.92 | ALDH1A1 (0.60) | LPAR1LPAR3ALDH1A1CNR1CNR2 | |
| SCHEMBL3257919 | 0.92 | ALDH1A1 (0.60) | LPAR1LPAR3ALDH1A1CNR1CNR2 | |
| SCHEMBL9456741 | 0.92 | ALDH1A1 (0.60) | LPAR1LPAR3ALDH1A1CNR1CNR2 | |
| SCHEMBL2782946 | 0.92 | ALDH1A1 (0.60) | LPAR1LPAR3ALDH1A1CNR1CNR2 | |
| SCHEMBL9718660 | 0.92 | ALDH1A1 (0.60) | LPAR1LPAR3ALDH1A1CNR1CNR2 | |
| SCHEMBL2782935 | 0.92 | ALDH1A1 (0.60) | LPAR1LPAR3ALDH1A1CNR1CNR2 | |
| SCHEMBL4094364 | 0.92 | ALDH1A1 (0.60) | LPAR1LPAR3ALDH1A1CNR1CNR2 | |
| SCHEMBL9718817 | 0.92 | ALDH1A1 (0.60) | LPAR1LPAR3ALDH1A1CNR1CNR2 | |
| SCHEMBL4199161 | 0.92 | ALDH1A1 (0.60) | LPAR1LPAR3ALDH1A1CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230293447-A1 | CLEAVABLE LIPIDIC COMPOUNDS, COMPOSITIONS CONTAINING THEREOF, AND USES THEREOF | SANOFI PASTEUR (FR) | 2023-09-21 | — | — | US | disclosed |
| US-20230293447-A1 | CLEAVABLE LIPIDIC COMPOUNDS, COMPOSITIONS CONTAINING THEREOF, AND USES THEREOF | SANOFI PASTEUR (FR) | 2023-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230293447-A1 | CLEAVABLE LIPIDIC COMPOUNDS, COMPOSITIONS CONTAINING THEREOF, AND USES THEREOF | MTTP, CETP, LNPEP | LPAR1 64/4885LPAR3 103/4885ALDH1A1 2000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.